Introduction The Q-Submission program offers a structured process for dialogue between the U.S. Food and Drug Administration (FDA) and entities developing medical devices. It provides a path for obtai...
<h2 id="introduction">Introduction</h2> <p>The Q-Submission program offers a structured process for dialogue between the U.S. Food and Drug Administration (FDA) and entities developing medical devices. It provides a path for obtaining the FDA's input on device development and clinical trial design, facilitating pre-regulatory discussions. The program includes various types of Q-Submissions tailored to different stages and questions in the development process, providing a roadmap for manufacturers.</p> <p>The FDA's draft guidance on the Q-Submission Program emphasizes the commitment to refining this pathway and offers detailed advice on securing feedback efficiently. Stakeholders are encouraged to submit comments on the draft guidance to contribute to the final version. The importance of the Q-Submission process lies in its role in facilitating device development and market access, ensuring manufacturers navigate both regulatory and post-…